Zogenix to Participate in the Leerink Partners 6th Annual Global Healthcare Conference
Feb 08, 2017 13:01 pm UTC| Business
EMERYVILLE, Calif., Feb. 08, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Stephen J....
Bridgeline Digital to Report Financial Results for the First Quarter of Fiscal 2017
Feb 08, 2017 13:01 pm UTC| Business
BURLINGTON, Mass., Feb. 08, 2017 -- Bridgeline Digital, Inc. (NASDAQ:BLIN), The Digital Engagement Company™, announced today that it will release its financial results for the first quarter ended December 31, 2016 on...
Bridgeline Digital to Report Financial Results for the First Quarter of Fiscal 2017
Feb 08, 2017 13:01 pm UTC| Business
BURLINGTON, Mass., Feb. 08, 2017 -- Bridgeline Digital, Inc. (NASDAQ:BLIN), The Digital Engagement Company™, announced today that it will release its financial results for the first quarter ended December 31, 2016 on...
Feb 08, 2017 13:01 pm UTC| Business
CHARLOTTESVILLE, Va., Feb. 08, 2017 -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer and other...
Feb 08, 2017 13:01 pm UTC| Business
CHARLOTTESVILLE, Va., Feb. 08, 2017 -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer and other...
Feb 08, 2017 13:01 pm UTC| Business
TEL AVIV, Israel, Feb. 08, 2017 -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat CNS and cognitive disorders, today announced that it will report...
Feb 08, 2017 13:01 pm UTC| Business
TEL AVIV, Israel, Feb. 08, 2017 -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat CNS and cognitive disorders, today announced that it will report...